文献速递白内障与屈光手术

微介入囊内晶状体核分解新技术及首次人体随机对照研究结果

Microinterventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomised controlled study.
PubMed 文献 · Br J Ophthalmol · 2018-04-18

一项前瞻性单盲多术者随机对照试验纳入101眼3‒4+级核性白内障,比较单纯扭动超声乳化与联合miLOOP囊内晶状体核分解的效果。结果显示对照组平均累积分散能量(CDE)较miLOOP组高53%(32.8±24.9 vs 21.4±13.1,p=0.004),两组内皮细胞丢失相似(7‒8%,p=0.561),无miLOOP直接相关并发症。

要点

  • miLOOP辅助可降低晚期白内障超声乳化能量需求,对照组CDE较miLOOP组高53%(p=0.004)。
  • 两组术后内皮细胞丢失相似(7‒8%,p=0.561),无miLOOP直接相关并发症。
  • 囊膜撕裂发生于人工晶状体植入或超声乳化阶段,未发生于miLOOP核分解阶段。

核心结论

  • 使用手动一次性miLOOP装置进行微介入囊内碎片化可实现一致的、无需超声的全层核分解,并显著改善晚期白内障的整体超声乳化效率。

研究设计与样本

  • 前瞻性单盲多术者干预性随机对照试验(ClinicalTrials.gov NCT02843594),纳入101例受试者的101眼3‒4+级核性白内障,随机分为单纯扭动超声乳化组(对照组)或联合miLOOP囊内晶状体核分解组(miLOOP组)。

主要发现

  • 仅纳入高级别晚期白内障,两组中超过85%的眼基线最佳矫正视力(BCVA)为20/200或更差。
  • 对照组平均CDE较miLOOP组高53%(32.8±24.9 vs 21.4±13.1,p=0.004)。
  • 术后内皮细胞丢失低且两组相似(7‒8%,p=0.561)。
  • 术后1个月BCVA在miLOOP组平均为20/27 Snellen,对照组为20/24。
  • 无miLOOP直接导致的并发症;2例囊膜撕裂发生于人工晶状体植入过程中,其余病例均发生于超声乳化过程中,miLOOP核分解阶段未发生囊膜撕裂。

关键数值与推荐

  • 对照组平均CDE为32.8±24.9,miLOOP组为21.4±13.1,对照组较miLOOP组高53%(p=0.004)。
  • 术后内皮细胞丢失两组均为7‒8%(p=0.561)。
  • 术后1个月BCVA:miLOOP组平均20/27 Snellen,对照组平均20/24。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To assess the safety and efficacy of microinterventional endocapsular nuclear fragmentation in moderate to severe cataracts. METHODS: This was a prospective single-masked multisurgeon interventional randomised controlled trial (ClinicalTrials.gov NCT02843594) where 101 eyes of 101 subjects with grade 3‒4+ nuclear cataracts were randomised to torsional phacoemulsification alone (controls) or torsional phacoemulsification with adjunctive endocapsular nuclear fragmentation using a manual microinterventional nitinol filament loop device (miLOOP group). Outcome measures were phacoemulsification efficiency as measured by ultrasound energy (cumulative dispersed energy (CDE) units) and fluidics requirements (total irrigation fluid used) as well as incidence of intraoperative and postoperative complications. RESULTS: Only high-grade advanced cataracts were enrolled with more than 85% of eyes with baseline best corrected visual acuity (BCVA) of 20/200 or worse in either group. Mean CDE was 53% higher in controls (32.8±24.9 vs 21.4±13.1 with miLOOP assistance) (p=0.004). Endothelial cell loss after surgery was low and similar between groups (7‒8%, p=0.561) One-month BCVA averaged 20/27 Snellen in miLOOP eyes and 20/24 in controls. No direct complications were caused by the miLOOP. In two cases, capsular tears occurred during IOL implantation and in all remaining cases during phacoemulsification, with none occurring during the miLOOP nucleus disassembly part of the procedure. CONCLUSIONS: Microinterventional endocapsular fragmentation with the manual, disposable miLOOP device achieved consistent, ultrasound-free, full-thickness nucleus disassembly and significantly improved overall phaco efficiency in advanced cataracts. TRIAL REGISTRATION NUMBER: NCT02843594.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ianchulev T, Chang DF, Koo E, et al. Microinterventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomised controlled study. Br J Ophthalmol. 2018. PMID: 29669780. doi:10.1136/bjophthalmol-2017-311766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。